Nitroglycerin DAK Tungurótartafla 0,25 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

nitroglycerin dak tungurótartafla 0,25 mg

orifarm healthcare a/s - glyceryli trinitras - tungurótartafla - 0,25 mg

Nitroglycerin DAK Tungurótartafla 0,5 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

nitroglycerin dak tungurótartafla 0,5 mg

orifarm healthcare a/s - glyceryli trinitras - tungurótartafla - 0,5 mg

Otrivin Menthol ukonserveret Nefúði, lausn 1 mg/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

otrivin menthol ukonserveret nefúði, lausn 1 mg/ml

haleon denmark aps - xylometazolinum hýdróklóríð - nefúði, lausn - 1 mg/ml

Otrivin ukonserveret Nefúði, lausn 1 mg/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

otrivin ukonserveret nefúði, lausn 1 mg/ml

haleon denmark aps - xylometazolinum hýdróklóríð - nefúði, lausn - 1 mg/ml

Ursochol (Ursodiol) Hart hylki 250 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

ursochol (ursodiol) hart hylki 250 mg

orifarm generics a/s - acidum ursodeoxycholicum inn - hart hylki - 250 mg

Bimervax Den Europæiske Union - islandsk - EMA (European Medicines Agency)

bimervax

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - bóluefni - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Parkódín Filmuhúðuð tafla 500 mg/10 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

parkódín filmuhúðuð tafla 500 mg/10 mg

teva b.v.* - paracetamolum inn; codeini phosphas hemihydricus - filmuhúðuð tafla - 500 mg/10 mg